| SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19 A Tsatsakis, D Calina, L Falzone, D Petrakis, R Mitrut, V Siokas, M Pennisi, ... Food and Chemical Toxicology 146, 111769, 2020 | 184 | 2020 |
| Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors D Vageli, H Kiaris, D Delakas, P Anezinis, A Cranidis, DA Spandidos Cancer letters 107 (2), 241-247, 1996 | 68 | 1996 |
| Hypoxia inducible factor-1alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma M Ioannou, R Papamichali, E Kouvaras, I Mylonis, D Vageli, T Kerenidou, ... Lung 187, 321-329, 2009 | 60 | 2009 |
| High-risk human papillomavirus (HPV) in parotid lesions D Vageli, G Sourvinos, M Ioannou, GK Koukoulis, DA Spandidos The International journal of biological markers 22 (4), 239-244, 2007 | 53 | 2007 |
| Biliary reflux as a causal factor in hypopharyngeal carcinoma: new clinical evidence and implications CT Sasaki, SG Doukas, J Costa, DP Vageli Cancer 125 (20), 3554-3565, 2019 | 40 | 2019 |
| The Effect of NNK, A Tobacco Smoke Carcinogen, on the miRNA and Mismatch DNA Repair Expression Profiles in Lung and Head and Neck Squamous Cancer Cells S Doukas, D Vageli, G Lazopoulos, D Spandidos, C Sasaki, A Tsatsakis Cells 9 (4), 1031, 2020 | 39 | 2020 |
| Comparative evaluation of non-informative HER-2 immunoreactions (2+) in breast carcinomas with FISH, CISH and QRT-PCR E Kostopoulou, D Vageli, D Kaisaridou, M Nakou, M Netsika, N Vladica, ... The Breast 16 (6), 615-624, 2007 | 39 | 2007 |
| miR-21, miR-155, miR-192, and miR-375 deregulations related to NF-kappaB activation in gastroduodenal fluid–induced early preneoplastic lesions of laryngeal mucosa in vivo CT Sasaki, DP Vageli Neoplasia 18 (6), 329-338, 2016 | 36 | 2016 |
| Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas D Vageli, Z Daniil, J Dahabreh, E Karagianni, DN Vamvakopoulou, ... Lung cancer 64 (3), 282-288, 2009 | 34 | 2009 |
| In vitro model for gastroduodenal reflux–induced nuclear factor‐kappaB activation and its role in hypopharyngeal carcinogenesis CT Sasaki, N Issaeva, DP Vageli Head & neck 38 (S1), E1381-E1391, 2016 | 33 | 2016 |
| Curcumin prevents the bile reflux‐induced NF‐κB‐related mRNA oncogenic phenotype, in human hypopharyngeal cells DP Vageli, SG Doukas, T Spock, CT Sasaki Journal of cellular and molecular medicine 22 (9), 4209-4220, 2018 | 32 | 2018 |
| Bile reflux and hypopharyngeal cancer DP Vageli, SG Doukas, PG Doukas, BL Judson Oncology Reports 46 (5), 1-14, 2021 | 30 | 2021 |
| Effect of TNF-α inhibitors on transcriptional levels of pro-inflammatory interleukin-33 and Toll-like receptors-2 and-9 in psoriatic plaques DP Vageli, A Exarchou, E Zafiriou, PG Doukas, S Doukas, ... Experimental and Therapeutic Medicine 10 (4), 1573-1577, 2015 | 30 | 2015 |
| Geographic variations of human papilloma virus infection and their possible impact on the effectiveness of the vaccination programme IN Mammas, D Vageli, DA Spandidos Oncology reports 20 (1), 141-145, 2008 | 30 | 2008 |
| Gastro-duodenal fluid induced Nuclear Factor-κappaB activation and early pre-malignant alterations in murine hypopharyngeal mucosa DP Vageli, ML Prasad, CT Sasaki Oncotarget 7 (5), 5892, 2016 | 28 | 2016 |
| Weakly Acidic Bile Is a Risk Factor for Hypopharyngeal Carcinogenesis Evidenced by DNA Damage, Antiapoptotic Function, and Premalignant Dysplastic Lesions In Vivo DPV CT Sasaki, SG Doukas, PG Doukas Cancers 13 (4), 852, 2021 | 27 | 2021 |
| Inhibition of NF-κB prevents the acidic bile-induced oncogenic mRNA phenotype, in human hypopharyngeal cells DP Vageli, SG Doukas, CT Sasaki Oncotarget 9 (5), 5876, 2018 | 25 | 2018 |
| NF‐κB inhibition reverses acidic bile‐induced miR‐21, miR‐155, miR‐192, miR‐34a, miR‐375 and miR‐451a deregulations in human hypopharyngeal cells SG Doukas, DP Vageli, CT Sasaki Journal of Cellular and Molecular Medicine 22 (5), 2922-2934, 2018 | 24 | 2018 |
| Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway. D Vageli, MG Ioannou, GK Koukoulis Oncology research 17 (9), 413-423, 2009 | 24 | 2009 |
| In vivo short-term topical application of BAY 11-7082 prevents the acidic bile–induced mRNA and miRNA oncogenic phenotypes in exposed murine hypopharyngeal mucosa CT Sasaki, SG Doukas, DP Vageli Neoplasia 20 (4), 374-386, 2018 | 22 | 2018 |
